Skip to main content
See every side of every news story
Published • loading... • Updated

Enanta Pharmaceuticals CEO Jay R. Luly to Retire in February 2027 After 23 Years; Tara Kieffer Named COO

Summary by Citybiz
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company developing small-molecule therapies for viral infections and immunological diseases, announced that... The post Enanta Pharmaceuticals CEO Jay R. Luly to Retire in February 2027 After 23 Years; Tara Kieffer Named COO appeared first on citybiz.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

citybiz broke the news on Wednesday, October 28, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal